Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.70 |
| ▸ | HPGD | P15428 | 5/20 | 0.70 |
| ▸ | FBP1 | P09467 | 3/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.70 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.70 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.70 |
| ▸ | DRD2 | P14416 | 1/20 | 0.70 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.70 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.70 |
| ▸ | DRD1 | P21728 | 1/20 | 0.70 |
| ▸ | MC5R | P33032 | 1/20 | 0.70 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.70 |
| ▸ | DRD3 | P35462 | 1/20 | 0.70 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.70 |
| ▸ | CCR2 | P41597 | 1/20 | 0.70 |
| ▸ | HTR6 | P50406 | 1/20 | 0.70 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.70 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzothiazyl Disulfide SCHEMBL29356396 | 0.83 | ALDH1A1 (1.00) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| Benzothiazyl Disulfide SCHEMBL11095350 | 0.83 | ALDH1A1 (1.00) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| SCHEMBL30005981 | 0.83 | ALDH1A1 (0.76) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| Benzothiazyl Disulfide SCHEMBL23527 | 0.83 | ALDH1A1 (1.00) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| SCHEMBL381557 | 0.83 | ALDH1A1 (0.76) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| SCHEMBL25340942 | 0.82 | ALDH1A1 (0.68) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| SCHEMBL29906665 | 0.82 | ALDH1A1 (0.68) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| SCHEMBL9799786 | 0.81 | ALDH1A1 (0.73) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| Benzothiazyl Disulfide SCHEMBL3787918 | 0.81 | ALDH1A1 (0.96) | ALDH1A1HSD17B10HPGDFBP1ALOX15 | |
| Benzothiazyl Disulfide SCHEMBL8609896 | 0.81 | ALDH1A1 (0.96) | ALDH1A1HSD17B10HPGDFBP1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024141927-A1 | A PROCESS FOR THE PREPARATION OF N, N-DISUBSTITUTED BENZOTHIAZOLE-2-SULFENAMIDES | NITREX CHEMICALS INDIA LIMITED (IN) | 2024-07-04 | — | — | WO | claimed |
| US-7291741-B2 | Process of production of n-alkyl-2-benzthiazolysulfeneimides, device for their production and method of their purification | DUSLO A.S. (SK) | 2007-11-06 | — | — | US | claimed |
| EP-1438301-B1 | PROCESS OF PRODUCTION OF N-ALKYL-2-BENZTHIAZOLYLSULFENEIMIDES AND METHOD OF THEIR PURIFICATION | DUSLO AS (SK) | 2005-09-07 | — | — | EP | claimed |
| US-20040210062-A1 | Process of production of n-alkyl-2-benzthiazolysulfeneimides, device for their production and method of their purification | DUSLO, A.S. (SK) | 2004-10-21 | — | — | US | claimed |
| EP-1438301-A1 | PROCESS OF PRODUCTION OF N-ALKYL-2-BENZTHIAZOLYLSULFENEIMIDES, DEVICE FOR THEIR PRODUCTION AND METHOD OF THEIR PURIFICATION | DUSLO, a.s. (SK) | 2004-07-21 | — | — | EP | claimed |
| WO-2003014096-A1 | PROCESS OF PRODUCTION OF N-ALKYL-2-BENZTHIAZOLYLSULFENEIMIDES, DEVICE FOR THEIR PRODUCTION AND METHOD OF THEIR PURIFICATION | DUSLO, A.S. (SK) | 2003-02-20 | — | — | WO | claimed |
| WO-2024141927-A1 | A PROCESS FOR THE PREPARATION OF N, N-DISUBSTITUTED BENZOTHIAZOLE-2-SULFENAMIDES | NITREX CHEMICALS INDIA LIMITED (IN) | 2024-07-04 | — | — | WO | disclosed |
| WO-2008089093-A2 | EFFICIENT PROCESSES FOR PREPARING STEROIDS AND VITAMIN D DERIVATIVES WITH THE UNNATURAL CONFIGURATION AT C20 (20 ALPHA-METHYL) FROM PREGNENOLONE | QUATRX PHARMACEUTICALS COMPANY (US) | 2008-07-24 | — | — | WO | disclosed |
| US-20080171728-A1 | Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone | QUATRX PHARMACEUTICALS CO. | 2008-07-17 | — | — | US | disclosed |
| US-7291741-B2 | Process of production of n-alkyl-2-benzthiazolysulfeneimides, device for their production and method of their purification | DUSLO A.S. (SK) | 2007-11-06 | — | — | US | disclosed |
| US-7291741-B2 | Process of production of n-alkyl-2-benzthiazolysulfeneimides, device for their production and method of their purification | DUSLO A.S. (SK) | 2007-11-06 | — | — | US | disclosed |
| EP-1438301-B1 | PROCESS OF PRODUCTION OF N-ALKYL-2-BENZTHIAZOLYLSULFENEIMIDES AND METHOD OF THEIR PURIFICATION | DUSLO AS (SK) | 2005-09-07 | — | — | EP | disclosed |
| EP-1438301-B1 | PROCESS OF PRODUCTION OF N-ALKYL-2-BENZTHIAZOLYLSULFENEIMIDES AND METHOD OF THEIR PURIFICATION | DUSLO AS (SK) | 2005-09-07 | — | — | EP | disclosed |
| US-4267340-A | BACTERICIDES; SYNTHESIS OF PENICILLINS AND CEPHALOSPORINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-05-12 | — | — | US | disclosed |
| US-4147696-A | VULCANIZATION ACCELERATORS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1979-04-03 | — | — | US | disclosed |
| US-4071527-A | Certain benzothiazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1978-01-31 | — | — | US | disclosed |
| US-4036847-A | ANTIBACTERIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1977-07-19 | — | — | US | disclosed |
| US-4009159-A | PENICILLINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1977-02-22 | — | — | US | disclosed |
| US-3993646-A | Process for the ring expansion of penicillins to cephalosporin compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-11-23 | — | — | US | disclosed |
| US-3979369-A | DIENE POLYMER | MONSANTO COMPANY (US) | 1976-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040210062-A1 | Process of production of n-alkyl-2-benzthiazolysulfeneimides, device for their production and method of their purification | ACR, APEH, INMT | ALDH1A1 4102/4885HSD17B10 3450/4885HPGD 4141/4885 |
| US-20080171728-A1 | Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone | CYP2R1, CYP24A1, VDR | ALDH1A1 1232/4885HSD17B10 86/4885HPGD 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.